Welcome! To our new Beyond Type 1 and Beyond Type 2 website! Hear from the team about the change.

Glucose Control Therapies

Finding simpler and more advanced ways to help people living with T1D control their glucose levels is one of the best ways to improve lives today.

This resource on Type 1 Diabetes Research was created in partnership with JDRF, an active partner of Beyond Type 1 at the time of publication, through the JDRF – Beyond Type 1 Alliance.


Finding simpler and more advanced ways to help people living with type 1 diabetes control their blood glucose levels is one of the best ways to improve lives today. With recent advances in technology, approval of hybrid-closed loop systems and new drug classes being investigated, there has never been a better time to have diabetes. Glucose control therapy research focuses three core areas:

  • Artificial pancreas (AP) technologies such as the recently approved Control-IQ from Tandem Diabetes Care
  • Next-generation insulin classes such as ultra-fast insulin, and “smart” insulin that can automatically react to the changes in the blood glucose levels
  • Investigation into other drug classes such as SGLT inhibitors to improve blood glucose management

Helping people with type 1 diabetes (T1D) manage their blood glucose levels not only lowers the risk for future complications, it makes every day easier to get through without constantly worrying about your numbers!

To learn more about all the great T1D research being funded by JDRF, visit their research and impact page here.